e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
COPD diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impairment of membranous and vascular components of pulmonary diffusion and plasma endothelin-1 in patients with liver cirrhosis with and without COPD
S. Langwieler, T. Wex, M. Peter, J. Schreiber (Magdeburg, Magdebuerg, Germany)
Source:
Annual Congress 2011 - COPD diagnosis
Session:
COPD diagnosis
Session type:
Thematic Poster Session
Number:
3570
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Langwieler, T. Wex, M. Peter, J. Schreiber (Magdeburg, Magdebuerg, Germany). Impairment of membranous and vascular components of pulmonary diffusion and plasma endothelin-1 in patients with liver cirrhosis with and without COPD. Eur Respir J 2011; 38: Suppl. 55, 3570
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Endothelin-1 level and central arterial stiffness in patients with COPD and hepatic cirrhosis
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Association between diffusion capacity and endothelial function in patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Year: 2018
Role of IL-11 in vascular function of pulmonary fibrosis patients
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
Arterial stiffness and endothelial dysfunction in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Pulmonary vascular changes in COPD and idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2006 - Clinical physiology
Year: 2006
Endogenous and nitrovasodilator-induced release of NO in the airways of end-stage cystic fibrosis patients
Source: Eur Respir J 2010; 36: 682-683
Year: 2010
Pulmonary hypertension and endothelial dysfunction in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 605s
Year: 2007
PP309 – Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis
Source: ERS Lung Science Conference 2021
Year: 2021
Time-course changes in pulmonary haemodynamics in patients with idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation (LT)
Source: Eur Respir J 2004; 24: Suppl. 48, 668s
Year: 2004
Association between endothelial function and pulmonary function in patients with chronic obstructive pulmonary disease
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Evaluation of pulmonary function and functional capacity in patients with liver cirrhosis
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
Increased polysialylation in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Source: Eur Respir J 2007; 30: 715-721
Year: 2007
Endothelin-1 level of functional tests and arterial deoxygenation in patients with COPD and cirrhosis
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
Correction of endothelial dysfunction in patients with COPD, IPF
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
Pulmonary vascular and cardiac impairment in interstitial lung disease
Source: Eur Respir Rev 2017; 26: 160128
Year: 2017
Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 173s
Year: 2001
Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations
Source: Eur Respir Rev 2014; 23: 350-355
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept